G
Glenn M. Chertow
Researcher at Stanford University
Publications - 830
Citations - 94517
Glenn M. Chertow is an academic researcher from Stanford University. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 128, co-authored 764 publications receiving 82401 citations. Previous affiliations of Glenn M. Chertow include University of Groningen & Fresenius Medical Care.
Papers
More filters
Journal ArticleDOI
Chronic kidney disease and cardiovascular therapeutics: time to close the evidence gaps.
Tara I. Chang,Glenn M. Chertow +1 more
TL;DR: Patients with CKD are often less likely to receive evidence-based therapies such as aspirin, beta-blockers, antiplatelet agents, or statins following an acute CVD event, driven in part by fear of adverse side effects, coupled with uncertainty regarding the relative efficacy of these therapies in CKD.
Journal ArticleDOI
Removing Race from eGFR calculations: Implications for Urologic Care.
Fernandino L. Vilson,Bogdana Schmidt,Lee W. White,Simon John Christoph Soerensen,Calyani Ganesan,Alan C. Pao,Ekene Enemchukwu,Glenn M. Chertow,John T. Leppert +8 more
TL;DR: The role of race in estimation of glomerular filtration rate equations and raced-based medicine has been discussed in this paper, where the authors discuss the consequences of removing race from these equations, potential alternatives, and how these changes may affect Black patients receiving urologic care.
Comprar Brenner and Rector's The Kidney, 9th Edition. Expert Consult - Online and Print 2-Volume Set | Philip A. Marsden | 9781416061939 | Saunders
TL;DR: Tienda online donde Comprar Brenner and Rector's The Kidney, 9th Edition - Online and Print 2-Volume Set al precio 443,10 € de Philip A. Marsden | Glenn M. Chertow | Maarten W. CherTow.
Journal ArticleDOI
Early Delays in Insurance Coverage and Long-term Use of Home-based Peritoneal Dialysis.
TL;DR: Extending retroactive coverage for preparatory dialysis services could increase PD use and reduce overall Medicare spending in the uninsured and increase the likelihood of switching to peritoneal dialysis.
Journal ArticleDOI
Karnofsky Performance Score-Failure to Thrive as a Frailty Proxy?
TL;DR: In this article, the variability, reliability, and trends in the Karnofsky Performance Status (KPS) among patients on the kidney transplant waitlist were investigated, and the authors found substantial variability in KPS reporting, in which 27% of the patients had scores that varied widely with 20-80 points in difference.